More so looking for private investors. They can't dillute they need the market cap at $50 mill to meet listing requirements. That won't help at this price.
The inevitable funding cuts to healthcare is becoming a worry for all of these biotech companies. You see a lot of them trading at their lows currently. Too much confusion in the white house.
News 
Market Data 
Discover 
